Current concepts review: Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement

Journal of Bone and Joint Surgery

Volumn 88, Issue 11, 2006, Pages 2487-2500

  Jiranek, William A ^a   Hanssen, Arlen D ^b   Greenwald, A Seth ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c Lutheran Hospital Cleveland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BONE CEMENT; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; STEROID; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG VEHICLE;

ALLERGIC REACTION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIOMECHANICS; DIABETES MELLITUS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HEALTH CARE COST; HEMOPHILIA; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; JOINT PROSTHESIS; LOW DRUG DOSE; MALNUTRITION; OBESITY; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; STEROID THERAPY; TREATMENT INDICATION; ARTHROPLASTY; COMPARATIVE STUDY; DRUG HYPERSENSITIVITY; ECONOMICS; INFECTION; SURGICAL INFECTION; VEHICLES;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT; BACTERIAL INFECTIONS; BONE CEMENTS; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; HUMANS; PROSTHESIS-RELATED INFECTIONS; SURGICAL WOUND INFECTION; VEHICLES;

EID: 33750823074     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.E.01126     Document Type: Review

References (122)

1. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63:342-53.
2. Duncan CP, Masri BA. The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr Course Lect. 1995;44:305-13.
3. Hanssen AD, Rand JA, Osmon DR. Treatment of the infected total knee arthroplasty with insertion of another prosthesis. The effect of antibiotic-impregnated bone cement. Clin Orthop Relat Res. 1994;309:44-55.
4. Springer BD, Lee GC, Osmon D, Haidukewych GJ, Hanssen AD, Jacofsky DJ. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res. 2004;427:47-51.
5. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty. 1996;11:939-44.
6. Maathuis PG, Neut D, Busscher HJ, van der Mei HC, van Horn JR. Perioperative contamination in primary total hip arthroplasty. Clin Orthop Relat Res. 2005;433:136-9.
7. Gristina AG, Shibata Y, Giridhar G, Kreger A, Myrvik QN. The giycocalyx, biofilm, microbes, and resistant infection. Semin Arthroplasty, 1994;5:160-70.
8. Gristina AG. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin Orthop Relat Res. 1994;298;106-18.
9. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am. 1985;67:264-73.
10. Oga M, Sugioka Y, Hobgood CD, Gristina AG, Myrvik QN. Surgical biomaterials and differential colonization by Staphylococcus epidermidis. Biomaterials. 1988;9:285-9.
11. Oga M, Arizono T, Sugioka Y. Bacterial adherence to bioinert and bioactive materials studied in vitro. Acta Orthop Scand. 1993;64:273-6.
12. Verheyen CC, Dhert WJ, de Blieck-Hogervorst JM, van der Reijden TJ, Petit PL, de Groot K. Adherence to a metal, polymer and composite by Staphylococcus aureus and Staphylococcus epidermidis. Biomaterials. 1993;14:383-91.
13. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237:1588-95.
14. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-8.
15. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J. 2000;46:S47-52.
16. Erratum in: ASAIO J. 2001;47:99.
17. Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier W, Busch R, Stemberger A. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J Antimicrob Chernother. 2003;51:585-91.
18. Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP, Raschke M. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003;32:521-31.
19. Dell'Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N. Suppression of drug-resistant staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis. 2004;190:318-20.
20. Chang CC, Merritt, K. Microbial adherence on poly(methyl methacrylate) (PMMA) surfaces. J Biomed Mater Res. 1992;26:197-207.
21. Oga M, Arizono T, Sugioka Y, Naylor PT, Myrvik QN, Gristina AG. The inhibition of bacterial adhesion to a tobramycin-impregnated polymethylmethacrylate substratum. J Long Term Eff Med Implants. 1992;1:321-8.
22. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ, Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop Scand. 2000;71:625-9.
23. Lawson KJ, Marks KE, Brems J, Rehm S. Vancomycin vs tobramycin elution from polymethylmethacrylate: an in vitro study. Orthopedics. 1990;13:521-4.
24. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty. 1999;14:209-14.
25. DeLuise M, Scott CP. Addition of hand-blended generic tobramycin in bone cement: effect on mechanical strength. Orthopedics. 2004;27:1289-91.
26. Lewis G, Janna S, Bhattaram A. Influence of the method of blending an antibiotic powder with an acrylic bone cement powder on physical, mechanical, and thermal properties of the cured cement. Biomaterials. 2005;26:4317-25.
27. Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ. The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand. 2003;74:670-6.
28. Baker AS, Greenham LW. Release of gentamicin from acrylic bone cement. Elution and diffusion studies. J Bone Joint Surg Am. 1988;70:1551-7.
29. DiCicco M, Duong T, Chu A, Jansen SA. Tobramycin and gentamycin elution analysis between two in situ polymerizable orthopedic composites. J Biomed Mater Res B Appl Biomater. 2003;65:137-49.
30. Fletcher MD, Spencer RF, Langkamer VG, Lovering AM. Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta Orthop Scand. 2004;75:173-6.
31. Powles JW, Spencer RF, Lovering AM. Gentamicin release from old cement during revision hip arthroplasty. J Bone Joint Surg Br. 1998;80:607-10.
32. Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, Ghisellini F, Ritter MA. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty. 2002;17:619-26.
33. Adams K, Couch L, Cierny G, Calhoun J, Mader JT. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res. 1992;278:244-52.
34. Heck D, Rosenberg A, Schink-Ascani M, Garbus S, Kiewitt T. Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States. J Arthroplasty. 1995;10:470-5.
35. Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990. Acta Orthop Scand. 1993;64:497-506.
36. Espehaug B, Engesaeter LB, Vollset SE, Havelin Ll, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register. 1987 to 1995. J Bone Joint Surg Br. 1997;79:590-5.
37. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin Ll. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand. 2003;74:644-51.
38. Best AJ, Fender D, Harper WM, McCaskie AW, Oliver K, Gregg PJ. Current practice in primary total hip replacement: results from the National Hip Replacement Outcome Project. Ann R Coll Surg Engl. 1998;80:350-5.
39. Erratum in: Ann R Coll Surg Engl. 1999;81:11.
40. Petty W, Spanier S, Shuster JJ. Prevention of infection after total joint replacement. Experiments with a canine model. J Bone Joint Surg Am. 1988;70:536-9.
41. Nijhof MW, Dhert WJ, Fleer A, Vogely HC, Verbeut AJ. Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement. J Biomed Mater Res. 2000;52:754-61.
42. Nijhof MW, Stallmann HP, Vogely HC, Fleer A, Schouls LM, Dhert WJ, Verbout AJ. Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model. J Biomed Mater Res. 2000;52:709-15.
43. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am. 2002;84:759-62.
44. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br. 2001;83:691-5.
45. McQueen M, Littlejohn A, Hughes SP. A comparison of systemic cefuroxime and cefuroxime loaded bone cement in the prevention of early infection after total joint replacement. Int Orthop. 1987;11:241-3.
46. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition. J Arthroplasty. 2004:19(4 Suppl 1):73-7.
47. Josefsson G, Kolmert L. Prophylaxis with systematic antibiotics versus gentamicin bone cement in total hip arthroplasty. A ten-year survey of 1,688 hips. Clin Orthop Relat Res. 1993;292:210-4.
48. Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop Relat Res. 1984;190:96-108.
49. Lynch M, Esser MP, Shelley P, Wroblewski BM. Deep infection in Charnley low-friction arthroplasty. Comparison of plain and gentamicin-loaded cement. J Bone Joint Surg Br. 1987;69:355-60.
50. Lidgren L. Joint prosthetic infections: a success story. Acta Orthop Scand. 2001;72:553-6.
51. Lautenschlager EP, Jacobs JJ, Marshall GW, Meyer PR Jr. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res. 1976;10:929-38.
52. Lautenschlager EP, Marshall GW, Marks KE, Schwartz J, Nelson CL. Mechanical strength of acrylic bone cements impregnated with antibiotics. J Biomed Mater Res. 1976;10:837-45.
53. Moran JM, Greenwald AS, Matejczyk MB. Effect of gentamicin on shear and interface strengths of bone cement. Clin Orthop Relat Res. 1979;141:96-101.
54. Seldes RM, Winiarsky R, Jordan LC, Baldini T, Brause B, Zodda F, Sculco TP. Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer. J Bone Joint Surg Am. 2005;87:268-72.
55. Davies JP, Harris WH. Effect of hand mixing tobramycin on the fatigue strength of Simplex P. J Biomed Mater Res. 1991;25:1409-14.
56. Davies JP, O'Connor DO, Burke DW, Harris WH. Influence of antibiotic impregnation on the fatigue life of Simplex P and Palacos R acrylic bone cements, with and without centrifugation. J Biomed Mater Res. 1989;23:379-97.
57. Postak PD, Greenwald AS. Assuring cement fixation: all mixing systems are NOT the same. Proc Am Acad Orthop Surg. 2003;4:656.
58. Postak PD, Greenwald AS. The influence of antibiotics on the fatigue life of acrylic bone cement: assuring clinical structural integrity. Presented as a scientific exhibit at the Annual Meeting of the American Academy of Orthopaedic Surgeons: 2005 Feb 23-27; Washington, DC.
59. Chohfi M, Langlais F, Fourastier J, Minet J, Thomazeau H, Cormier M. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop. 1998;22:171-7.
60. Sterling GJ, Crawford S, Potter JH, Koerbin G, Crawford R. The pharmacokinetics of Simplex-tobramycin bone cement. J Bone Joint Surg Br. 2003;85:646-9.
61. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004;427:101-6.
62. Isefuku S, Joyner CJ, Simpson AH. Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma. 2003;17:212-6.
63. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE. Bone toxicity of locally applied aminoglycosides. J Orthop Trauma. 1995;9:401-6.
64. Edin ML, Miclau T, Lester GE, Lindsey RW, Dahners LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res. 1996;333:245-51.
65. Richter-Hintz D, Rieker J, Rauch L, Homey B. [Sensitivity to constituents of bone cement in a patient with joint prosthesis]. Hautarzt. 2004;55:987-9. German.
66. Bertazzoni Minelli E, Caveiari C, Benini A. Release of antibiotics from polymethylmethacrylate cement. J Chemother. 2002;14:492-500.
67. Thomes B, Murray P, Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br. 2002;84:758-60.
68. Kendall RW, Duncan CP, Beauchamp CP. Bacterial growth on antibiotic-loaded acrylic cement. A prospective in vivo retrieval study. J Arthroplasty. 1995;10:817-22.
69. Kendall RW, Duncan CP, Smith JA, Ngui-Yen JH. Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin Orthop Relat Res. 1996;329:273-80.
70. Neut D, van de Belt H, Stokroos I, van Horn JR, van der Mei HC, Busscher HJ. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47:885-91.
71. Ramage G, Tunney MM, Patrick S, Gorman SP, Nixon JR. Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials. Biomaterials. 2003;24:3221-7.
72. Arciola CR, Campoccia D, Montanaro L. Effects on antibiotic resistance of Staphylococcus epidermidis following adhesion to polymethylmethacrylate and to silicone surfaces. Biomaterials. 2002;23:1495-502.
73. van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand. 2001;72:557-71.
74. Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagulase-negative staphylococci. J Bone Joint Surg Br. 1989;71:851-5.
75. Sanzen L, Walder M. Antibiotic resistance of coagulase-negative staphylococci in an orthopaedic department. J Hosp Infect. 1988;12:103-8.
76. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, Hanna D, Ramage G. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br. 1998;80:568-72.
77. Montanaro L, Cavedagna D, Baldassarri L, Arciola CR. Adhesion of a Staphylococcus aureus strain to biomaterials does not select methicillin-resistant mutants. New Microbiol. 2001;24:57-61.
78. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002;292:107-13.
79. Naylor PT, Myrvik QN, Gristina A. Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci. Clin Orthop Relat Res. 1990;261:126-33.
80. Gristina AG, Jennings RA, Naylor PT, Myrvik QN, Webb LX. Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci. Antimicrob Agents Chemother. 1989;33:813-6.
81. Oga M, Arizono T, Sugioka Y, Naylor PT, Myrvik QN, Gristina AG. The inhibition of bacterial adhesion to a tobramycin-impregnated polymethylmethacrylate sub-stratum. J Long Term Eff Med Implants. 1992;1:321-8.
82. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother. 1996;40:2675-9.
83. Hanssen AD, Osmon DR. The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clin Orthop Relat Res. 1999;369:124-38.
84. Blom AW, Brown J, Taylor AH, Pattison G, Whitehouse S, Bannister GC. Infection after total knee arthroplasty. J Bone Joint Surg Br. 2004;86:688-91.
85. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am. 2005;87:1222-8.
86. Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoli E, Baron JA, Harris WH, Poss R, Katz JN. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 2003;85:20-6.
87. Best JT. Revision total hip and total knee arthroplasty. Orthop Nurs. 2005;24:174-9.
88. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis. 2003;36:1157-61.
89. Smabrekke A, Espehaug B, Havelin LI, Fumes O. Operating time and survival of primary total hip replacements: an analysis of 31,745 primary cemented and uncemented total hip replacements from local hospitals reported to the Norwegian Arthroplasty Register 1987-2001. Acta Orthop Scand. 2004;75:524-32.
90. Lee GC, Pagnano MW, Hanssen AD. Total knee arthroplasty after prior bone or joint sepsis about the knee. Clin Orthop Relat Res. 2002;404:226-31.
91. Jerry GJ Jr, Rand JA, Ilstrup D. Old sepsis prior to total knee arthroplasty. Clin Orthop Relat Res. 1988;236:135-40.
92. Hofmann AA, Goldberg T, Tanner AM, Kurtin SM. Treatment of infected total knee arthroplasty using an articulating spacer: 2-to 12-year experience. Clin Orthop Relat Res. 2005;430:125-31.
93. Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35-9.
94. Sharma S, Nicol F, Hullin MG, McCreath SW. Long-term results of the uncemented low contact stress total knee replacement in patients with rheumatoid arthritis. J Bone Joint Surg Br. 2005;87:1077-80.
95. Amenabar PP, Carrion M, Apablaza D, Paulos J. [Total knee arthroplasty in patients with rheumatoid arthritis]. Rev Med Chil. 2004;132:337-45. Spanish.
96. Liu HT Chiu FY, Chen CM, Chen TH. The combination of systemic antibiotics and antibiotic impregnated cement in primary total knee arthroplasty in patients of rheumatoid arthritis-evaluation of 60 knees. J Chin Med Assoc. 2003;66:533-6.
97. Yang K, Yeo SJ, Lee BP, Lo NN. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty. 2001;16:102-6.
98. England SP, Stern SH, Insali JN, Windsor RE. Total knee arthroplasty in diabetes mellitus. Clin Orthop Relat Res. 1990;260:130-4.
99. Meding JB, Reddleman K, Keating ME, Klay A, Ritter MA, Faris PM, Berend ME. Total knee replacement in patients with diabetes mellitus. Clin Orthop Relat Res. 2003;416:208-16.
100. Tannenbaum DA, Matthews LS, Grady-Benson JC. Infection around joint replacements in patients who have a renal or liver transplantation. J Bone Joint Surg Am. 1997;79:3643.
101. Murzic WJ. McCollum DE. Hip arthroplasty for osteonecrosis after renal transplantation. Clin Orthop Relat Res. 1994;299:212-9.
102. Lo NN, Tan JS, Tan SK, Vathsala A. Results of total hip replacement in renal transplant recipients. Ann Acad Med Singapore. 1992;21:694-8.
103. Stromboni M, Menguy F, Hardy P, Leparc JM, Lortat-Jacob A, Benoit J. [Total hip arthroplasty and femoral head osteonecrosis in renal transplant recipients]. Rev Chir Orthop Reparatrice Appar Mot. 2002;88:467-74. French.
104. Namba RS, Paxton L, Fithian DC, Stone ML. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty. 2005;20(7 Suppl 3):46-50.
105. Powell DL, Whitener CJ, Dye CE, Ballard JO, Shaffer ML, Eyster ME. Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic. Haemophilia. 2005;11:233-9.
106. Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J Bone Joint Surg Am. 2005;87:85-91.
107. Meding JB, Keating EM, Ritter MA, Faris PM, Berend ME. Long-term followup of posterior-cruciate-retaining TKR in patients with rheumatoid arthritis. Clin Orthop Relat Res. 2004;428:146-52.
108. Creighton MG, Callaghan JJ, Olejniczak JP, Johnston RC. Total hip arthroplasty with cement in patients who have rheumatoid arthritis. A minimum ten-year follow-up study. J Bone Joint Surg Am. 1998;80:1439-46.
109. Kaspar S, de V de Beer J. Infection in hip arthroplasty after a previous injection of steroid. J Bone Joint Surg Br. 2005;87:454-7.
110. Grimes CJ, Younathan MT, Lee WC. The effect of preoperative total parenteral nutrition on surgery outcomes. J Am Diet Assoc. 1987;87:1202-6.
111. Klein JD, Hey LA, Yu CS, Klein BB, Coufal FJ, Young EP, Marshall LF, Garfin SR. Perioperative nutrition and postoperative complications in patients undergoing spinal surgery. Spine. 1996;21:2676-82.
112. Koval KJ, Maurer SG, Su ET, Aharonoff GB, Zuckerman JD. The effects of nutritional status on outcome after hip fracture. J Orthop Trauma. 1999;13:164-9.
113. Kudsk KA, Tolley EA, DeWitt RC, Janu PG, Blackwell AP, Yeary S, King BK. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003;27:1-9.
114. Lavernia CJ, Sierra RJ, Baerga L. Nutritional parameters and short term outcome in arthroplasty. J Am Coll Nutr. 1999;18:274-8.
115. Starker PM, LaSala PA, Askanazi J, Todd G, Hensle TW, Kinney JM. The influence of preoperative total parenteral nutrition upon morbidity and mortality. Surg Gynecol Obstet. 1986;162:569-74.
116. Jevsevar DS, Karlin LI. The relationship between preoperative nutritional status and complications after an operation for scoliosis in patients who have cerebral palsy. J Bone Joint Surg Am. 1993;75:880-4.
117. Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients. Relationship to postoperative wound complications. J Arthroplasty. 1991;6:321-5.
118. Del Savio GC, Zelicof SB, Wexler LM, Byrne DW, Reddy PD, Fish D, Ende KA. Preoperative nutritional status and outcome of elective total hip replacement. Clin Orthop Relat Res. 1996;326:153-61.
119. Marin LA, Salido JA, Lopez A, Silva A. Preoperative nutritional evaluation as a prognostic tool for wound healing. Acta Orthop Scand. 2002;73:2-5.
120. Nelson CL, Evans RP, Blaha JD, Calhoun J, Henry SL, Patzakis MJ. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin Orthop Relat Res. 1993;295:96-101.
121. Al-Maiyah M, Hill D, Bajwa A, Slater S, Patil P, Port A, Gregg PJ. Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br. 2005;87:1256-8.
122. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844-50.